Literature DB >> 19472995

Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.

Daniel Pla1, Andrés Francesch, Pilar Calvo, Carmen Cuevas, Rosa Aligué, Fernando Albericio, Mercedes Alvarez.   

Abstract

Herein is reported the design and synthesis of poly(ethylene glycol) derivatives of Lamellarin D with the aim of modulating their physicochemical properties and improving the biological activity. Mono-, di-, and tri-PEG conjugates with improved solubility were obtained in 18-57% overall yields from the corresponding partially protected phenolic derivatives of Lamellarin D. Conjugates 1-9 were tested in a panel of three human tumor cell lines (MDA-MB-231 breast, A-549 lung, and HT-29 colon) to evaluate their cytotoxicity. Several compounds exhibited enhanced cellular internalization, and more than 85% of the derivatives showed a lower GI(50) than Lam-D. Furthermore, cell cycle arrest at G2 phase and apoptotic cell-death pathways were determined for Lamellarin D and these derivatives.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19472995     DOI: 10.1021/bc800503k

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  4 in total

1.  ORGANOCOPPER-MEDIATED TWO-COMPONENT SN2'-SUBSTITUTION CASCADE TOWARDS N-FUSED HETEROCYCLES.

Authors:  D Chernyak; V Gevorgyan
Journal:  Chem Heterocycl Compd (N Y)       Date:  2012-03-01       Impact factor: 1.277

2.  Palladium-catalyzed intramolecular carbopalladation/cyclization cascade: access to polycyclic N-fused heterocycles.

Authors:  Dmitri Chernyak; Vladimir Gevorgyan
Journal:  Org Lett       Date:  2010-11-08       Impact factor: 6.005

3.  Design, Synthesis and Cytotoxicity Evaluation of New 2-Aryl-5, 6-Dihydropyrrolo[2, 1-a]Isoquinoline Derivatives as Topoisomerase Inhibitors.

Authors:  Samaneh Kakhki; Sorayya Shahosseini; Afshin Zarghi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 4.  Anticancer properties of lamellarins.

Authors:  Christian Bailly
Journal:  Mar Drugs       Date:  2015-02-19       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.